Toggle light / dark theme

Despite the initial excitement and flashy headlines, all of these early ventures failed or switched focus away from aging. Most of these companies and their backers underestimated the complexity, costs, and time it would take to discover and develop a drug. Recent estimates suggest that developing a new drug takes over https://www.sciencedirect.com/science/article/abs/pii/S1359644623002428” rel=“noopener”>10 years and costs upwards of $6.1 billion and the failure rates exceed 90%. This figure reflects the immense difficulty of identifying therapeutic targets, conducting preclinical and clinical trials, and navigating the regulatory landscape. When it comes to developing a drug specifically for aging, the challenges multiply, making it much more difficult to design effective interventions and demonstrate their efficacy in clinical trials.

Fast forward to today, and a new generation of longevity biotechnology companies with a more conservative approach than their predecessors has emerged. Companies like http://www.bioagelabs.com” rel=“noopener”>BioAge Labs and http://www.insilico.com” rel=“noopener”>Insilico Medicine are using artificial intelligence (AI) to discover drugs that target specific chronic diseases or biological processes closely associated with aging. Instead of trying to develop therapies for aging directly, these companies focus on conditions that are closely linked to the aging process like obesity, muscle wasting, fibrosis, anemia, and even cancer… The strategy is to develop drugs for these diseases that could later be repurposed to address aging more broadly. And while in the technology industry we try to focus on moving very fast to win, here we prepare to play a very long game and focus on resilience and novelty rather than putting all eggs in one basket and failing miserably like dozens of companies in the past three decades.

I have been off Facebook, will leave again because I always get harassed by Facebook. I haven’t used it ib months, and I already have broken ubknown rules🙄. I did share info to Lifeboat via e-mail. I think I will join X like everyone else…but this was a cool video.


No, this is not Japan but Kenya! East Africa just got its first ever Robot restaurant and it is located in Nairobi. This really fun cafe style eatery is ideal for families with kids as the young ones will simply love the robot waiters.

The robots moving around the serving the food is definitely the main attraction of this robot cafe but the food is also very good and fairly affordable. So if you ever wondered where to eat in Nairobi well try this place out!

Robo Cafe Nairobi location:
Lana Plaza (first floor), Oloitoktok Rd, Nairobi, Kenya.

WANNA SUPPORT US? HERE IS HOW

In the ongoing battle against cancer, a new AI approach is being explored that holds the potential to revolutionize the future of personalized cancer treatments.

The technology, which is an amalgamation of artificial intelligence, molecular dynamics simulations, and network analysis, aims to predict the binding sites on cancer-related proteins. This will pave the way for a faster development of treatments tailored for individual cancer patients.

The study was led by Dr. Rafael Bernardi, an associate professor of biophysics in the Department of Physics at Auburn University. As part of a collaborative effort with the University of Basel and ETH Zurich, the team is breaking barriers on how we understand and fight cancer.

But what if you’re a manufacturer without the budget, bandwidth or time to invest in advanced digital transformation right now? You can still take practical steps to move forward. Start with fundamental data collection and analytic tools to lay the groundwork. Leveraging visibility solutions like barcode scanning, wearables or other basic Internet of Things (IoT) devices can help monitor machines and provide insights and improvements.

Quality is the final piece of the equation. Once you’re further down the path to transformation, implement visibility solutions and augment and upskill workers with technology to optimize quality. To drive quality even further, add advanced automation solutions. You don’t have to boil the ocean on your digital transformation journey—take it one step at a time from wherever you’re starting.

Most manufacturers (87%) in Zebra’s study agree it’s a challenge to pilot new technologies or move beyond the pilot phase, yet they plan to advance digital maturity by 2029. With the right technology tools and solutions in place to advance visibility, augment workers and optimize quality, they will get there.

The University of Texas at Austin this week announced that it has opened its undergraduate robotics program to high school applicants. The honors program is one of the first in the U.S. that allows incoming freshmen to apply for the program as part of their initial admission application. It’s a clear indication that robotics is no longer in the realm of hyper-specialized graduate and doctorate programs.

The minor is tied to a handful of other majors, including aerospace engineering, electrical and computer engineering, computational engineering, computer science and mechanical engineering. Each forms a foundational piece of an eventual robotics major. With the rise of robotics in high school STEAM teaching, the program is designed to maintain incoming freshmen’s interest in the growing space.

A wheeled bot rolls across the floor. A soft-bodied robotic star bends its five legs, moving with an awkward shuffle.

Powered by conventional electricity via plug or battery, these simple robotic creations would be unremarkable, but what sets these two robots apart is that they are controlled by a living entity: a king oyster mushroom.

By growing the mushroom’s mycelium, or rootlike threads, into the robot’s hardware, a team led by Cornell University researchers has engineered two types of robots that sense and respond to the environment by harnessing electrical signals made by the fungus and its sensitivity to light.